A Phase I trial to investigate the pharmacokinetics and ECG effects of single doses of linaprazan glurate administered as oral tablets to healthy participants
CX842A2104
Phase 1 other active
Quick answer
A Phase I trial to investigate the pharmacokinetics and ECG effects of single doses of linaprazan glurate administered as oral tablets to healthy participants for Erosive Gastroesophageal Reflux Disease (eGERD) is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Erosive Gastroesophageal Reflux Disease (eGERD)
- Phase
- Phase 1
- Modality
- other
- Status
- active